CHEK1 and neoplasm: Since Chk1 is crucial for the G2 checkpoint activation and survival after treatment with DNA damaging agents, we speculate that inhibition of Chk1 might provide a molecular explanation for the enhancement of tumor sensitivity to chemotherapeutic agents by HDACis.